A Real-World Study of Pyrrolitinib Maleate Tablets for HER-2-Positive Early or Locally Advanced Breast Cancer After Adjuvant Trastuzumab Therapy
Clinical trial NCT06470347 · UNKNOWN
Trial details
- NCT number
- NCT06470347
- Sponsor
- Zunyi Medical College
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-01
- Primary completion
- 2024-11-01
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.